Hokkaido, Japan

Akihiro Ishii


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Akihiro Ishii: Innovator in Antiviral Compounds

Introduction

Akihiro Ishii is a notable inventor based in Hokkaido, Japan. He has made significant contributions to the field of antiviral research, particularly focusing on arenavirus proliferation inhibitors. With a total of two patents to his name, Ishii's work is recognized for its potential impact on public health.

Latest Patents

Ishii's latest patents include an arenavirus growth inhibitor comprising a polycyclic carbamoyl pyridone derivative. This invention provides a compound with antiviral activity, specifically targeting arenavirus proliferation. The compound is designed to inhibit the growth of both Old World arenaviruses, such as the Lassa virus and lymphocytic choriomeningitis virus, and New World arenaviruses, including the Junin virus. The patent outlines a compound represented by a specific formula, which includes various chemical groups that enhance its efficacy as a medicament.

Career Highlights

Throughout his career, Akihiro Ishii has worked with esteemed institutions, including Hokkaido University and Shionogi & Company Limited. His research has contributed to advancements in antiviral therapies, showcasing his commitment to addressing viral infections.

Collaborations

Ishii has collaborated with notable colleagues, including Akihiko Sato and Makoto Kawai. These partnerships have fostered a collaborative environment that enhances the innovation process in his research endeavors.

Conclusion

Akihiro Ishii's contributions to antiviral research through his patents highlight his role as a significant inventor in the field. His work continues to pave the way for new therapeutic options against arenaviruses, demonstrating the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…